Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD)
2011
CD40 and CD45 in Microglial Activation and HIV Associated Dementia
publication
Evidence: moderate
Author Information
Author(s): Jon Salemi, Demian F. Obregon, Anthony Cobb, Spenser Reed, Edin Sadic, Jingji Jin, Francisco Fernandez, Jun Tan, Brian Giunta
Primary Institution: University of South Florida
Hypothesis
CD40 and CD45 modulation of microglial activation states may represent critical therapeutic targets for HIV associated dementia.
Conclusion
The study suggests that CD45 acts as a regulatory 'off switch' for harmful microglial activation in HIV associated dementia.
Supporting Evidence
- Microglial dysfunction is linked to neurodegenerative disorders like HIV associated dementia.
- CD40 promotes a harmful microglial state, while CD45 can help switch it off.
- Chronic inflammation in the brain is exacerbated by HIV infection.
- Microglia play a significant role in the pathogenesis of both HIV associated dementia and Alzheimer's disease.
Takeaway
Microglia, the brain's immune cells, can become harmful in HIV associated dementia, but a protein called CD45 can help turn off this harmful state.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website